BOTHELL, Wash.--(BUSINESS WIRE)--Alder Biopharmaceuticals, Inc., an emerging antibody therapeutics company, today announced the appointment of Mark D. Young, Ph.D., as Senior Vice President of Pharmaceutical Operations.
BOTHELL, Wash.--(BUSINESS WIRE)--Alder Biopharmaceuticals, Inc., an emerging antibody therapeutics company, today announced the appointment of Mark D. Young, Ph.D., as Senior Vice President of Pharmaceutical Operations.
